
Articles
-
4 days ago |
dermatologytimes.com | Marie Bosslett
The National Psoriasis Foundation (NPF) has recently expanded its Seal of Recognition program to include prescription drugs approved by the US Food and Drug Administration (FDA), making Arcutis Biotherapeutics’ Zoryve (roflumilast) the first therapy to achieve this recognition.1 The categorization includes the cream 0.3% and topical foam 0.3% versions of roflumilast.
-
5 days ago |
dermatologytimes.com | Maddi Hebebrand |Marie Bosslett
To stay informed with the latest conference insights, subscribe to receive our eNewsletters. Discover expert insights and practice management tips at the Fall Clinical PA/NP Conference in Orlando, featuring top dermatology professionals.
-
5 days ago |
dermatologytimes.com | Marie Bosslett
To stay informed with the latest conference insights, subscribe to receive our eNewsletters. Track It Right: The Key to PA Business SuccessDiscover essential business metrics for PAs in dermatology, empowering practice ownership and driving sustainable growth through data-driven strategies.
-
6 days ago |
dermatologytimes.com | Marie Bosslett
Author(s): Chronic hand eczema remains challenging to diagnose and treat, but emerging JAK inhibitors offer promising therapeutic options. GLP-1 receptor agonists are being explored as adjunctive treatments in psoriatic disease, providing new therapeutic avenues. Heather Gates, PA-C, led a workshop on innovative aesthetics techniques and technologies, highlighting advancements in the field.
-
6 days ago |
dermatologytimes.com | Marie Bosslett |Darrell S. Rigel
At the 10th Annual Fall Clinical PA/NP Conference in Orlando, Florida, Darrell Rigel, MD, MS, clinical professor at New York University, adjunct clinical professor at UT Southwestern, and consultant dermatologist at Cooper Clinic in Dallas, presented a session titled “Real-World Data and Patient Perspectives: A Guide for PAs and NPs in Actinic Keratosis (AK) Care.” In his talk, Rigel shared practical, evidence-based strategies for improving AK treatment outcomes while enhancing the patient...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →